C79.5 Secondary malignant neoplasm of bone and bone marrow

Name of the Condition

• Secondary Malignant Neoplasm of Bone and Bone Marrow
• Also known as metastatic bone disease involving bone marrow.

Summary

Secondary malignant neoplasm of bone and bone marrow refers to cancer that has spread from a primary tumor site to the bone and its marrow. This condition occurs when cancer cells detach from the primary tumor, travel through the bloodstream or lymphatic system, and establish new tumors in the bone and marrow. It is not a primary bone cancer but a metastatic manifestation of another cancer.

Causes

This condition is caused by the spread of cancer cells from a primary tumor, such as breast, prostate, lung, or kidney cancer, to the bone and bone marrow. The process involves cancer cells invading nearby tissues, entering the circulatory or lymphatic systems, and colonizing the bone marrow, where they grow and form secondary tumors.

Risk Factors

• Having a primary cancer with known metastatic potential (e.g., breast, prostate, lung).
• Advanced stage of the primary cancer.
• Genetic predispositions or mutations.
• Previous history of cancer.
• Prolonged survival from a primary cancer, increasing the likelihood of metastasis.

Symptoms

• Persistent bone pain, often worsening at night.
• Pathologic fractures due to weakened bones.
• Anemia, leukopenia, or thrombocytopenia from bone marrow involvement.
• Fatigue and general weakness.
• Hypercalcemia, leading to symptoms like nausea, thirst, and confusion.
• Swelling or tenderness in the affected area.

Diagnosis

Imaging studies, including X-rays, CT scans, MRI, or bone scans, are used to detect bone lesions. Blood tests assess calcium levels, complete blood counts, and tumor markers. A biopsy of the bone or marrow confirms the presence of metastatic cancer cells and helps identify the primary tumor source.

Treatment Options

• Chemotherapy: Targets cancer cells throughout the body.
• Radiation therapy: Reduces pain and controls tumor growth in bones.
• Bisphosphonates or denosumab: Strengthens bones and reduces fracture risk.
• Targeted therapy or immunotherapy: Addresses specific cancer mechanisms.
• Pain management: Includes analgesics and palliative care.

Prognosis and Follow-Up

Prognosis depends on the primary cancer type, extent of metastasis, and treatment response. Regular follow-up with imaging and blood tests monitors disease progression. Management focuses on symptom control, maintaining quality of life, and addressing complications like fractures or hypercalcemia.

Complications

• Pathologic fractures.
• Spinal cord compression.
• Hypercalcemia.
• Bone marrow suppression leading to anemia or infection.
• Reduced mobility and functional impairment.

Lifestyle & Prevention

• Maintain bone health with calcium and vitamin D (if appropriate).
• Engage in weight-bearing exercise to strengthen bones.
• Avoid smoking and excessive alcohol, which weaken bones.
• Follow primary cancer treatment plans to reduce metastasis risk.
• Monitor for symptoms and report changes to healthcare providers promptly.

When to Seek Professional Help

Seek immediate care for severe bone pain, sudden mobility issues, or signs of spinal cord compression (e.g., numbness, weakness). Contact a provider for unexplained fatigue, weight loss, or persistent symptoms related to bone or marrow involvement.

Tips for Medical Coders

Code C79.5 is used for secondary malignant neoplasms of bone and bone marrow. Document the primary cancer site and confirmation of metastasis (e.g., biopsy, imaging) to support coding. Ensure differentiation from primary bone cancers (e.g., osteosarcoma) and other metastatic sites. Follow ICD-10-CM guidelines for coding secondary neoplasms.